Filed pursuant to Rule 424(b)(3)
Registration Statement No. 333-261949
Prospectus Supplement No. 1
(To Prospectus Dated January 14, 2022)
Grab Holdings Limited
2,473,860,634 CLASS A ORDINARY SHARES,
16,000,000 WARRANTS TO PURCHASE CLASS A ORDINARY SHARES AND
16,000,000 CLASS A ORDINARY SHARES UNDERLYING WARRANTS
This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated January 14, 2022 (as supplemented to date, the “Prospectus”), related to the offer and sale from time to time by the selling securityholders identified in the Prospectus or their pledgees, donees, transferees, or other successors-in-interest of (1) up to 2,473,860,634 Class A Ordinary Shares, (2) up to 16,000,000 Warrants, and (3) up to 16,000,000 Class A Ordinary Shares issuable upon exercises of the Warrants, with the information contained in our Report on Form 6-K, furnished with the Securities and Exchange Commission on March 3, 2022 (the “Form 6-K”). Accordingly, we have attached Exhibit 99.1 of the Form 6-K to this prospectus supplement.
This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
Our Class A Ordinary Shares and Warrants are listed on the Nasdaq Stock Market LLC, or “NASDAQ”, under the trading symbols “GRAB” and “GRABW,” respectively. On March 2, 2022, the closing price of our Class A Ordinary Shares was $5.23 per share, and the closing price of our Warrants was $1.37 per warrant.
We may further amend or supplement the Prospectus and this prospectus supplement from time to time by filing amendments or supplements as required. You should read the entire Prospectus, this prospectus supplement and any amendments or supplements carefully before you make your investment decision.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 9 of the Prospectus for a discussion of information that should be considered in connection with an investment in our securities.
Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is March 3, 2022.